Both are referenced as growth hormone secretagogues in performance and longevity clinic listings. MK-677 is orally active while ipamorelin is typically injectable. Compare clinic listings by service scope and monitoring protocols.
MK-677 and ipamorelin are often referenced in performance or longevity contexts. Clinics vary in how they position each option within protocols. Use this page to compare provider models and monitoring standards.
Move from this comparison into the peptide pages and relevant clinic profiles.
A growth hormone secretagogue referenced in performance and longevity clinic listings. Not a peptide in the traditional sense.
A GH secretagogue typically administered by injection in clinic protocols.
| Category | MK-677 | Ipamorelin |
|---|---|---|
| Directory context | Informational clinic and treatment comparison context. | Informational clinic and treatment comparison context. |
| Common goals | Compare how clinics frame suitability, monitoring, and expected use cases. | Compare how clinics frame suitability, monitoring, and expected use cases. |
| Guidance note | Informational listing only; suitability requires clinician review. | Informational listing only; suitability requires clinician review. |
Next step
Use city pages and peptide-specific pages to move from general research into actual provider shortlists. That usually gives a better buying picture than comparing drug names alone.
Doctor-led peptide advisory consultations in central London. Every protocol is built around comprehensive bloodwork and personally led by Dr Ethan Hausman-Marquis, who reports a PhD from the Karolinska Institute, with compounds sourced from GMP-certified, EMA-regulated pharmacies.
Doctor-led clinical governanceFrom £600
LiveNow Longevity is a physician-led longevity and peptide clinic in Las Vegas — built on a simple promise: transparent medicine with no markup on your meds. Founded by board-certified neurologist Dr. Charles Kamen, MD, every patient starts with an $88 medical evaluation including baseline labs. From there, care can include peptide therapy, anti-aging treatments, GLP-1 weight loss (semaglutide and tirzepatide), NAD+ therapy, hormone optimization, and recovery support. In person in Las Vegas, or via telehealth across Nevada.
Physician-led by Dr. Charles Kamen, MD
Menon Health is a Mayfair-based peptide therapy clinic founded by Dr Mukil Menon, a GMC-registered physician and one of the first doctors to prescribe medical peptide therapy in the UK. Before establishing Menon Health, Dr Menon served as UK medical director at Koniver Wellness, launching the clinic at Soho House London. He continues to practise within the NHS alongside his private consultations, ensuring his protocols stay grounded in current medical standards. The clinic offers doctor-led, prescription-based peptide therapy alongside regenerative cell complex treatments, bloods and diagnostics, and IV therapy. All formulations are sourced from GMP-certified, EMA-regulated pharmacies and dispensed as pre-filled pens, vials, or multi-peptide syringes — Menon Health's approach to combining multiple peptides in a single dose is designed to improve precision and patient adherence. Based at 64 North Row in Mayfair, London, Menon Health serves patients across the UK, Europe, Canada, and the United States, with consultations available in person or remotely.
GMC-registered physiciansFrom £195
360 MD Austin is a peptide clinic in Austin, United States. Listed services cover BPC-157, CJC-1295, ipamorelin, semaglutide and tirzepatide. Its public profile references medical credentials, and the listing has been independently reviewed and verified by Peptide Clinic Finder.
discovery:directory_researchChoose based on provider quality and monitoring rather than delivery format. Both are clinic-dependent and require clinician oversight.
How do MK-677 and ipamorelin differ?
MK-677 is an orally active secretagogue with a longer duration, while ipamorelin is an injectable peptide secretagogue with a shorter, more selective action. Clinics weigh these differences alongside monitoring and goals.
Are they ever discussed together?
Some clinics reference them within broader growth hormone support discussions, but the format, dosing, and monitoring differ, so clinician guidance matters.
What matters most when comparing providers?
Clinical governance: licensed assessment, clear eligibility criteria, transparent monitoring, and realistic, non-promissory framing of outcomes.
For clinics
Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.